世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

医薬品グリセリン市場:用途別(賦形剤、ケア製品としてのグリセリン)。世界の機会分析および産業予測、2020-2030年


Pharmaceutical Glycerine Market By Application (Excipient, Glycerin As Care Product): Global Opportunity Analysis and Industry Forecast, 2020-2030

医薬品グリセリンの世界市場は、2020年に8,989万ドルで、2021年から2030年までCAGR11.0%を記録し、2030年には2億4,648万ドルに達すると予測されています。 世界の医薬品グリセリン市場の総量は、2020年に132,000... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Allied Market Research
アライドマーケットリサーチ
2022年5月31日 US$5,769
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
180 英語

 

サマリー

医薬品グリセリンの世界市場は、2020年に8,989万ドルで、2021年から2030年までCAGR11.0%を記録し、2030年には2億4,648万ドルに達すると予測されています。
世界の医薬品グリセリン市場の総量は、2020年に132,000トンでしたが、2030年には243,641トンに達すると予測され、2021年から2030年までのCAGRは6.6%を記録しています。
グリセロールは無色のシロップ状の液体で、医療用には下剤として、浣腸として経口投与したり、坐薬の形で使用されます。グリセリンは、食品、化学、製薬、バイオテクノロジー産業において、甘味料、保湿剤、溶剤、微生物培養の餌料として、さまざまな用途に使用されています。
医薬品用グリセリン市場は、抗菌性および抗ウイルス性の特性により、著しい成長を遂げています。グリセリンは、滑らかさを向上させ、潤滑性を与え、皮膚損傷を治療する手段として、医薬品製剤に広く使用されています。また、アレルゲン免疫療法、咳止めシロップ、エリキシル剤、去痰剤、グリセリン石鹸、水性パーソナル潤滑剤などにも使用されています。ニトログリセリンは、慢性狭心症、胸痛、心臓病の治療のための最も一般的な治療法の1つです。グリセリンの医薬品は、ヘルスケア産業において、乾燥肌、肌荒れ、鱗状肌、かゆみ、軽度の肌荒れの治療や予防に保湿剤として使用されています。製薬業界におけるグリセリンの需要の伸び。グリセリンは、スキンケア、ヘアケア、オーラルケア、化粧品などの分野で、保湿剤およびエモリエント剤として使用され、身体の質感の向上、ケラチノサイトの増殖の誘導、傷の治癒、メラニン濃度の低減などに役立てられています。さらに、スキンケアやビューティー&パーソナルケア業界の成長、人口の高齢化、自意識の高まりも、市場成長に寄与すると予想される追加要因の1つです。これとは別に、パーソナルケアおよび化粧品業界におけるグリセリンの高い需要も、予測期間中に市場の成長を加速させると推測されます。グリセリンは、手指消毒剤や口腔ケア製品に広く使用されています。COVID-19の流行により、手指消毒剤の需要が急増し、手指消毒剤メーカーがグリセリンを大量に調達する必要性が高まりました。一方、世界保健機関(WHO)の統計によると、35億人が罹患しているとされる口腔疾患の増加も、市場の成長を促進すると予想されています。
天然素材のパーソナルケア製品や化粧品に対する消費者の志向の高まりは、今後数年間でグリセリン市場の成長を促進するように設定されています。これは主に、化学成分の有害な影響に関する大衆の間で増加する意識プログラムのおかげで発生します。
このレポートでは、医薬品グリセリン市場は、アプリケーションと地域に基づいて検討されています。アプリケーションに基づいて、市場は賦形剤とケア製品としてのグリセリンとして分割されます。賦形剤はさらに、充填剤・可塑剤、可溶化剤・乳化剤、溶剤、希釈剤・基剤、潤滑剤、増粘剤、甘味料に分けられます。地域別では、北米、欧州、アジア太平洋、LAMEAに分かれて分析されています。
地域別では、2020年にアジア太平洋地域が市場を支配し、予測期間中もその地位を維持すると予想されています。これは、マレーシア、インドネシア、インド、日本などのグリセリン生産上位国の高い存在感が、この地域の生産技術や生産能力確保の面で競争環境をもたらしているためです。また、中国、インド、東南アジアの最終用途産業が順調に成長していることから、この地域は当面の間、最速の成長を記録すると予想されています。
世界の医薬品グリセリン市場で事業を展開している主な企業は、Archer Daniels Midland Company、Cargill Inc、DuPont de Nemours, Inc、Emery Oleo chemicals Group、Godrej Group、Procter and Gamble Co.、試薬、再生可能エネルギーグループ株式会社、The Chemical Company、Universal Preserv-A-Chem, Inc.などです。これらのプレイヤーは、製品の発売、コラボレーション、M&Aを主要な開発戦略として採用しています。
ステークホルダーにとっての主なメリット
本レポートは、差し迫った投資ポケットを解明するために、現在のトレンドと将来の予測とともに、世界の医薬品グリセリン市場規模に関する詳細な分析を提供します。
2021年から2030年までの市場分析を提供しており、利害関係者が市場の優勢な機会を活用することを可能にすると期待されます。
地域に関する包括的な分析は、地域市場を理解し、戦略的な事業計画を促進し、優勢な機会を決定するのに役立ちます。
主要企業のプロファイルと成長戦略は、世界の医薬品グリセリン市場成長の競争的展望を理解するために徹底的に分析されています。

[S1】amr rdから更新し、それを最終的に考慮してください。

ページTOPに戻る


目次

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Excipient
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Glycerin As Care Product
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: PHARMACEUTICAL GLYCERINE MARKET, BY REGION
5.1 Overview
5.1.1 Market size and forecast
5.2 North America
5.2.1 Key trends and opportunities
5.2.2 North America Market size and forecast, by Application
5.2.3 North America Market size and forecast, by country
5.2.3.1 U.S.
5.2.3.1.1 Market size and forecast, by Application
5.2.3.2 Canada
5.2.3.2.1 Market size and forecast, by Application
5.2.3.3 Mexico
5.2.3.3.1 Market size and forecast, by Application
5.3 Europe
5.3.1 Key trends and opportunities
5.3.2 Europe Market size and forecast, by Application
5.3.3 Europe Market size and forecast, by country
5.3.3.1 Germany
5.3.3.1.1 Market size and forecast, by Application
5.3.3.2 France
5.3.3.2.1 Market size and forecast, by Application
5.3.3.3 United Kingdom
5.3.3.3.1 Market size and forecast, by Application
5.3.3.4 Italy
5.3.3.4.1 Market size and forecast, by Application
5.3.3.5 Spain
5.3.3.5.1 Market size and forecast, by Application
5.3.3.6 Rest of Europe
5.3.3.6.1 Market size and forecast, by Application
5.4 Asia-Pacific
5.4.1 Key trends and opportunities
5.4.2 Asia-Pacific Market size and forecast, by Application
5.4.3 Asia-Pacific Market size and forecast, by country
5.4.3.1 Japan
5.4.3.1.1 Market size and forecast, by Application
5.4.3.2 China
5.4.3.2.1 Market size and forecast, by Application
5.4.3.3 Australia
5.4.3.3.1 Market size and forecast, by Application
5.4.3.4 India
5.4.3.4.1 Market size and forecast, by Application
5.4.3.5 South Korea
5.4.3.5.1 Market size and forecast, by Application
5.4.3.6 Rest of Asia-Pacific
5.4.3.6.1 Market size and forecast, by Application
5.5 LAMEA
5.5.1 Key trends and opportunities
5.5.2 LAMEA Market size and forecast, by Application
5.5.3 LAMEA Market size and forecast, by country
5.5.3.1 Brazil
5.5.3.1.1 Market size and forecast, by Application
5.5.3.2 Saudi Arabia
5.5.3.2.1 Market size and forecast, by Application
5.5.3.3 South Africa
5.5.3.3.1 Market size and forecast, by Application
5.5.3.4 Rest of LAMEA
5.5.3.4.1 Market size and forecast, by Application
CHAPTER 6: COMPANY LANDSCAPE
6.1. Introduction
6.2. Top winning strategies
6.3. Product Mapping of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Key developments
CHAPTER 7: COMPANY PROFILES
7.1 DuPont
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Product portfolio
7.1.5 Business performance
7.1.6 Key strategic moves and developments
7.2 cargill
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Product portfolio
7.2.5 Business performance
7.2.6 Key strategic moves and developments
7.3 Universal Preserv A Chem Inc.
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Product portfolio
7.3.5 Business performance
7.3.6 Key strategic moves and developments
7.4 TCC Glycerin
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Product portfolio
7.4.5 Business performance
7.4.6 Key strategic moves and developments
7.5 Procter and Gamble Co
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Product portfolio
7.5.5 Business performance
7.5.6 Key strategic moves and developments
7.6 Godrej Group
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Product portfolio
7.6.5 Business performance
7.6.6 Key strategic moves and developments
7.7 Emery Oleochemicals Group
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Product portfolio
7.7.5 Business performance
7.7.6 Key strategic moves and developments
7.8 Archer Daniels Midland Company
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Product portfolio
7.8.5 Business performance
7.8.6 Key strategic moves and developments
7.9 Renewable Energy Group, Inc.
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Product portfolio
7.9.5 Business performance
7.9.6 Key strategic moves and developments
7.10 Reagents Company
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Product portfolio
7.10.5 Business performance
7.10.6 Key strategic moves and developments


LIST OF TABLES
TABLE 1. GLOBAL PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 2. PHARMACEUTICAL GLYCERINE MARKET REVENUE, FOR EXCIPIENT, BY REGION , 2020-2030,($MILLION)
TABLE 3. PHARMACEUTICAL GLYCERINE MARKET EXCIPIENT BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. PHARMACEUTICAL GLYCERINE MARKET REVENUE, FOR GLYCERIN AS CARE PRODUCT, BY REGION , 2020-2030,($MILLION)
TABLE 5. PHARMACEUTICAL GLYCERINE MARKET GLYCERIN AS CARE PRODUCT BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. PHARMACEUTICAL GLYCERINE MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 7. NORTH AMERICA PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 8. NORTH AMERICA PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 9. U.S. PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 10. CANADA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 11. MEXICO PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 12. EUROPE PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 13. EUROPE PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. GERMANY PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 15. FRANCE PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 16. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 17. ITALY PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 18. SPAIN PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 19. REST OF EUROPE PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 20. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 21. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. JAPAN PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 23. CHINA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 24. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 25. INDIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 26. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 27. REST OF ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 28. LAMEA PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 29. LAMEA PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 30. BRAZIL PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 31. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 32. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 33. REST OF LAMEA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 34.DUPONT: COMPANY SNAPSHOT
TABLE 35.DUPONT: OPERATING SEGMENTS
TABLE 36.DUPONT: PRODUCT PORTFOLIO
TABLE 37.DUPONT: NET SALES,
TABLE 38.DUPONT: KEY STRATERGIES
TABLE 39.CARGILL: COMPANY SNAPSHOT
TABLE 40.CARGILL: OPERATING SEGMENTS
TABLE 41.CARGILL: PRODUCT PORTFOLIO
TABLE 42.CARGILL: NET SALES,
TABLE 43.CARGILL: KEY STRATERGIES
TABLE 44.UNIVERSAL PRESERV A CHEM INC.: COMPANY SNAPSHOT
TABLE 45.UNIVERSAL PRESERV A CHEM INC.: OPERATING SEGMENTS
TABLE 46.UNIVERSAL PRESERV A CHEM INC.: PRODUCT PORTFOLIO
TABLE 47.UNIVERSAL PRESERV A CHEM INC.: NET SALES,
TABLE 48.UNIVERSAL PRESERV A CHEM INC.: KEY STRATERGIES
TABLE 49.TCC GLYCERIN: COMPANY SNAPSHOT
TABLE 50.TCC GLYCERIN: OPERATING SEGMENTS
TABLE 51.TCC GLYCERIN: PRODUCT PORTFOLIO
TABLE 52.TCC GLYCERIN: NET SALES,
TABLE 53.TCC GLYCERIN: KEY STRATERGIES
TABLE 54.PROCTER AND GAMBLE CO: COMPANY SNAPSHOT
TABLE 55.PROCTER AND GAMBLE CO: OPERATING SEGMENTS
TABLE 56.PROCTER AND GAMBLE CO: PRODUCT PORTFOLIO
TABLE 57.PROCTER AND GAMBLE CO: NET SALES,
TABLE 58.PROCTER AND GAMBLE CO: KEY STRATERGIES
TABLE 59.GODREJ GROUP: COMPANY SNAPSHOT
TABLE 60.GODREJ GROUP: OPERATING SEGMENTS
TABLE 61.GODREJ GROUP: PRODUCT PORTFOLIO
TABLE 62.GODREJ GROUP: NET SALES,
TABLE 63.GODREJ GROUP: KEY STRATERGIES
TABLE 64.EMERY OLEOCHEMICALS GROUP: COMPANY SNAPSHOT
TABLE 65.EMERY OLEOCHEMICALS GROUP: OPERATING SEGMENTS
TABLE 66.EMERY OLEOCHEMICALS GROUP: PRODUCT PORTFOLIO
TABLE 67.EMERY OLEOCHEMICALS GROUP: NET SALES,
TABLE 68.EMERY OLEOCHEMICALS GROUP: KEY STRATERGIES
TABLE 69.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 70.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 71.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 72.ARCHER DANIELS MIDLAND COMPANY: NET SALES,
TABLE 73.ARCHER DANIELS MIDLAND COMPANY: KEY STRATERGIES
TABLE 74.RENEWABLE ENERGY GROUP, INC.: COMPANY SNAPSHOT
TABLE 75.RENEWABLE ENERGY GROUP, INC.: OPERATING SEGMENTS
TABLE 76.RENEWABLE ENERGY GROUP, INC.: PRODUCT PORTFOLIO
TABLE 77.RENEWABLE ENERGY GROUP, INC.: NET SALES,
TABLE 78.RENEWABLE ENERGY GROUP, INC.: KEY STRATERGIES
TABLE 79.REAGENTS COMPANY: COMPANY SNAPSHOT
TABLE 80.REAGENTS COMPANY: OPERATING SEGMENTS
TABLE 81.REAGENTS COMPANY: PRODUCT PORTFOLIO
TABLE 82.REAGENTS COMPANY: NET SALES,
TABLE 83.REAGENTS COMPANY: KEY STRATERGIES


LIST OF FIGURES
FIGURE 1.PHARMACEUTICAL GLYCERINE MARKET SEGMENTATION
FIGURE 2.PHARMACEUTICAL GLYCERINE MARKET,2020-2030
FIGURE 3.PHARMACEUTICAL GLYCERINE MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.PHARMACEUTICAL GLYCERINE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.PHARMACEUTICAL GLYCERINE MARKET,BY APPLICATION,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF EXCIPIENT PHARMACEUTICAL GLYCERINE MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF GLYCERIN AS CARE PRODUCT PHARMACEUTICAL GLYCERINE MARKET,2020-2030(%)
FIGURE 14.PHARMACEUTICAL GLYCERINE MARKET BY REGION,2020
FIGURE 15.U.S. PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 16.CANADA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 17.MEXICO PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 18.GERMANY PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 19.FRANCE PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 20.UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 21.ITALY PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 22.SPAIN PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 23.REST OF EUROPE PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 24.JAPAN PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 25.CHINA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 26.AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 27.INDIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 28.SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 29.REST OF ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 30.BRAZIL PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 31.SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 32.SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 33.REST OF LAMEA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 34. TOP WINNING STRATEGIES, BY YEAR
FIGURE 35. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 36. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 37.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 38.COMPETITIVE DASHBOARD
FIGURE 39.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 40.DUPONT.: NET SALES ,($MILLION)
FIGURE 41.CARGILL.: NET SALES ,($MILLION)
FIGURE 42.UNIVERSAL PRESERV A CHEM INC..: NET SALES ,($MILLION)
FIGURE 43.TCC GLYCERIN.: NET SALES ,($MILLION)
FIGURE 44.PROCTER AND GAMBLE CO.: NET SALES ,($MILLION)
FIGURE 45.GODREJ GROUP.: NET SALES ,($MILLION)
FIGURE 46.EMERY OLEOCHEMICALS GROUP.: NET SALES ,($MILLION)
FIGURE 47.ARCHER DANIELS MIDLAND COMPANY.: NET SALES ,($MILLION)
FIGURE 48.RENEWABLE ENERGY GROUP, INC..: NET SALES ,($MILLION)
FIGURE 49.REAGENTS COMPANY.: NET SALES ,($MILLION)

 

ページTOPに戻る


 

Summary

The global pharmaceutical glycerin market was valued at $89.89 million in 2020, and is projected to reach $246.48 million by 2030, registering a CAGR of 11.0% from 2021 to 2030.
The total volume of global pharmaceutical glycerin market was 132,000 tons in 2020, and is projected to reach 243,641 tons by 2030, registering a CAGR of 6.6% from 2021 to 2030.
Glycerol is a colorless syrupy liquid that is used medically as a laxative, given orally as an enema, or in the form of suppositories. Glycerol has multiple uses in food, chemical, pharmaceutical, and biotechnological industries as a sweetener, a humectant, a solvent, or as feeding stock for microbial cultures.
The pharmaceutical glycerin market is witnessing tremendous growth, owing to antimicrobial and antiviral properties. It is widely used in pharmaceutical preparations as a means of improving smoothness, providing lubrication, and treating skin damage. It also finds its application in allergen immunotherapies, cough syrups, elixirs and expectorants, glycerin soaps, and water-based personal lubricants. Nitro-glycerin is one of the most common treatments for treating chronic angina, chest pain, and heart disease. The medication of Glycerin is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations in the healthcare industry. Growth in demand for glycerin in the pharmaceutical industry. Glycerin is used as a humectant and emollient in skincare, hair care, oral care, and cosmetics among others to enhance physical texture, inducing keratinocyte proliferation, healing wounds, and reducing melanin intensity. In addition, growing skincare and beauty & personal care industry, coupled with aging population and increasing self-consciousness are some of the additional factors anticipated to contribute toward the market growth. Apart from this, high demand for glycerin in the personal care and cosmetics industry is also estimated to accelerate growth of the market during the forecast period. Glycerin is used widely in hand sanitizers and in oral healthcare products. Owing to the COVID-19 pandemic, demand for hand sanitizers witnessed a massive surge, thereby leading to rise in need among manufacturers of hand sanitizers to source glycerin in high quantities. On the other hand, increase in oral health diseases globally, which according to the statistics by the World Health Organization (WHO) is recorded to affect 3.5 Billion people, is also anticipated to propel the market growth.
Rise in inclination of consumers toward natural personal care and cosmetics products is set to propel the glycerin market growth in the coming years. This mainly occurs, owing to increasing awareness programs among masses regarding harmful effects of chemical ingredients.
The pharmaceutical glycerin market in this report is studied on the basis of application and region. On the basis of application, the market is divided as excipient and glycerin as a care product. Excipients are further divided into fillers & plasticizer, solubilizer & emulsifier, solvent, diluent & base, lubricant, thickener, and sweetener. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Region wise, Asia-Pacific dominated the market in 2020, and is expected to maintain it in the forecast period, owing to the high presence of top glycerin-producing countries such as Malaysia, Indonesia, India, and Japan has resulted in a competitive environment in terms of production technologies and securing production capacities in the region. Also, on account of the favorable growth of end-use industries in China, India, and South East Asia, the region is expected to register the fastest growth during the foreseeable period.
The major players operating in the Global Pharmaceutical Glycerin market are Archer Daniels Midland Company, Cargill Inc., DuPont de Nemours, Inc., Emery Oleo chemicals Group, Godrej Group, Procter and Gamble Co., Reagents, Renewable Energy Group Inc., The Chemical Company, and Universal Preserv-A-Chem, Inc. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.
KEY BENEFITS FOR STAKEHOLDERS
The report provides in-depth analysis of the Global Pharmaceutical Glycerin market size along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the Global Pharmaceutical Glycerin market growth.

[S1]Update from amr rd and consider it final



ページTOPに戻る


Table of Contents

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Excipient
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Glycerin As Care Product
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: PHARMACEUTICAL GLYCERINE MARKET, BY REGION
5.1 Overview
5.1.1 Market size and forecast
5.2 North America
5.2.1 Key trends and opportunities
5.2.2 North America Market size and forecast, by Application
5.2.3 North America Market size and forecast, by country
5.2.3.1 U.S.
5.2.3.1.1 Market size and forecast, by Application
5.2.3.2 Canada
5.2.3.2.1 Market size and forecast, by Application
5.2.3.3 Mexico
5.2.3.3.1 Market size and forecast, by Application
5.3 Europe
5.3.1 Key trends and opportunities
5.3.2 Europe Market size and forecast, by Application
5.3.3 Europe Market size and forecast, by country
5.3.3.1 Germany
5.3.3.1.1 Market size and forecast, by Application
5.3.3.2 France
5.3.3.2.1 Market size and forecast, by Application
5.3.3.3 United Kingdom
5.3.3.3.1 Market size and forecast, by Application
5.3.3.4 Italy
5.3.3.4.1 Market size and forecast, by Application
5.3.3.5 Spain
5.3.3.5.1 Market size and forecast, by Application
5.3.3.6 Rest of Europe
5.3.3.6.1 Market size and forecast, by Application
5.4 Asia-Pacific
5.4.1 Key trends and opportunities
5.4.2 Asia-Pacific Market size and forecast, by Application
5.4.3 Asia-Pacific Market size and forecast, by country
5.4.3.1 Japan
5.4.3.1.1 Market size and forecast, by Application
5.4.3.2 China
5.4.3.2.1 Market size and forecast, by Application
5.4.3.3 Australia
5.4.3.3.1 Market size and forecast, by Application
5.4.3.4 India
5.4.3.4.1 Market size and forecast, by Application
5.4.3.5 South Korea
5.4.3.5.1 Market size and forecast, by Application
5.4.3.6 Rest of Asia-Pacific
5.4.3.6.1 Market size and forecast, by Application
5.5 LAMEA
5.5.1 Key trends and opportunities
5.5.2 LAMEA Market size and forecast, by Application
5.5.3 LAMEA Market size and forecast, by country
5.5.3.1 Brazil
5.5.3.1.1 Market size and forecast, by Application
5.5.3.2 Saudi Arabia
5.5.3.2.1 Market size and forecast, by Application
5.5.3.3 South Africa
5.5.3.3.1 Market size and forecast, by Application
5.5.3.4 Rest of LAMEA
5.5.3.4.1 Market size and forecast, by Application
CHAPTER 6: COMPANY LANDSCAPE
6.1. Introduction
6.2. Top winning strategies
6.3. Product Mapping of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Key developments
CHAPTER 7: COMPANY PROFILES
7.1 DuPont
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Product portfolio
7.1.5 Business performance
7.1.6 Key strategic moves and developments
7.2 cargill
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Product portfolio
7.2.5 Business performance
7.2.6 Key strategic moves and developments
7.3 Universal Preserv A Chem Inc.
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Product portfolio
7.3.5 Business performance
7.3.6 Key strategic moves and developments
7.4 TCC Glycerin
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Product portfolio
7.4.5 Business performance
7.4.6 Key strategic moves and developments
7.5 Procter and Gamble Co
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Product portfolio
7.5.5 Business performance
7.5.6 Key strategic moves and developments
7.6 Godrej Group
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Product portfolio
7.6.5 Business performance
7.6.6 Key strategic moves and developments
7.7 Emery Oleochemicals Group
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Product portfolio
7.7.5 Business performance
7.7.6 Key strategic moves and developments
7.8 Archer Daniels Midland Company
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Product portfolio
7.8.5 Business performance
7.8.6 Key strategic moves and developments
7.9 Renewable Energy Group, Inc.
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Product portfolio
7.9.5 Business performance
7.9.6 Key strategic moves and developments
7.10 Reagents Company
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Product portfolio
7.10.5 Business performance
7.10.6 Key strategic moves and developments


LIST OF TABLES
TABLE 1. GLOBAL PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 2. PHARMACEUTICAL GLYCERINE MARKET REVENUE, FOR EXCIPIENT, BY REGION , 2020-2030,($MILLION)
TABLE 3. PHARMACEUTICAL GLYCERINE MARKET EXCIPIENT BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. PHARMACEUTICAL GLYCERINE MARKET REVENUE, FOR GLYCERIN AS CARE PRODUCT, BY REGION , 2020-2030,($MILLION)
TABLE 5. PHARMACEUTICAL GLYCERINE MARKET GLYCERIN AS CARE PRODUCT BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. PHARMACEUTICAL GLYCERINE MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 7. NORTH AMERICA PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 8. NORTH AMERICA PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 9. U.S. PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 10. CANADA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 11. MEXICO PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 12. EUROPE PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 13. EUROPE PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. GERMANY PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 15. FRANCE PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 16. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 17. ITALY PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 18. SPAIN PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 19. REST OF EUROPE PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 20. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 21. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. JAPAN PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 23. CHINA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 24. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 25. INDIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 26. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 27. REST OF ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 28. LAMEA PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 29. LAMEA PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 30. BRAZIL PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 31. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 32. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 33. REST OF LAMEA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 34.DUPONT: COMPANY SNAPSHOT
TABLE 35.DUPONT: OPERATING SEGMENTS
TABLE 36.DUPONT: PRODUCT PORTFOLIO
TABLE 37.DUPONT: NET SALES,
TABLE 38.DUPONT: KEY STRATERGIES
TABLE 39.CARGILL: COMPANY SNAPSHOT
TABLE 40.CARGILL: OPERATING SEGMENTS
TABLE 41.CARGILL: PRODUCT PORTFOLIO
TABLE 42.CARGILL: NET SALES,
TABLE 43.CARGILL: KEY STRATERGIES
TABLE 44.UNIVERSAL PRESERV A CHEM INC.: COMPANY SNAPSHOT
TABLE 45.UNIVERSAL PRESERV A CHEM INC.: OPERATING SEGMENTS
TABLE 46.UNIVERSAL PRESERV A CHEM INC.: PRODUCT PORTFOLIO
TABLE 47.UNIVERSAL PRESERV A CHEM INC.: NET SALES,
TABLE 48.UNIVERSAL PRESERV A CHEM INC.: KEY STRATERGIES
TABLE 49.TCC GLYCERIN: COMPANY SNAPSHOT
TABLE 50.TCC GLYCERIN: OPERATING SEGMENTS
TABLE 51.TCC GLYCERIN: PRODUCT PORTFOLIO
TABLE 52.TCC GLYCERIN: NET SALES,
TABLE 53.TCC GLYCERIN: KEY STRATERGIES
TABLE 54.PROCTER AND GAMBLE CO: COMPANY SNAPSHOT
TABLE 55.PROCTER AND GAMBLE CO: OPERATING SEGMENTS
TABLE 56.PROCTER AND GAMBLE CO: PRODUCT PORTFOLIO
TABLE 57.PROCTER AND GAMBLE CO: NET SALES,
TABLE 58.PROCTER AND GAMBLE CO: KEY STRATERGIES
TABLE 59.GODREJ GROUP: COMPANY SNAPSHOT
TABLE 60.GODREJ GROUP: OPERATING SEGMENTS
TABLE 61.GODREJ GROUP: PRODUCT PORTFOLIO
TABLE 62.GODREJ GROUP: NET SALES,
TABLE 63.GODREJ GROUP: KEY STRATERGIES
TABLE 64.EMERY OLEOCHEMICALS GROUP: COMPANY SNAPSHOT
TABLE 65.EMERY OLEOCHEMICALS GROUP: OPERATING SEGMENTS
TABLE 66.EMERY OLEOCHEMICALS GROUP: PRODUCT PORTFOLIO
TABLE 67.EMERY OLEOCHEMICALS GROUP: NET SALES,
TABLE 68.EMERY OLEOCHEMICALS GROUP: KEY STRATERGIES
TABLE 69.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 70.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 71.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 72.ARCHER DANIELS MIDLAND COMPANY: NET SALES,
TABLE 73.ARCHER DANIELS MIDLAND COMPANY: KEY STRATERGIES
TABLE 74.RENEWABLE ENERGY GROUP, INC.: COMPANY SNAPSHOT
TABLE 75.RENEWABLE ENERGY GROUP, INC.: OPERATING SEGMENTS
TABLE 76.RENEWABLE ENERGY GROUP, INC.: PRODUCT PORTFOLIO
TABLE 77.RENEWABLE ENERGY GROUP, INC.: NET SALES,
TABLE 78.RENEWABLE ENERGY GROUP, INC.: KEY STRATERGIES
TABLE 79.REAGENTS COMPANY: COMPANY SNAPSHOT
TABLE 80.REAGENTS COMPANY: OPERATING SEGMENTS
TABLE 81.REAGENTS COMPANY: PRODUCT PORTFOLIO
TABLE 82.REAGENTS COMPANY: NET SALES,
TABLE 83.REAGENTS COMPANY: KEY STRATERGIES


LIST OF FIGURES
FIGURE 1.PHARMACEUTICAL GLYCERINE MARKET SEGMENTATION
FIGURE 2.PHARMACEUTICAL GLYCERINE MARKET,2020-2030
FIGURE 3.PHARMACEUTICAL GLYCERINE MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.PHARMACEUTICAL GLYCERINE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.PHARMACEUTICAL GLYCERINE MARKET,BY APPLICATION,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF EXCIPIENT PHARMACEUTICAL GLYCERINE MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF GLYCERIN AS CARE PRODUCT PHARMACEUTICAL GLYCERINE MARKET,2020-2030(%)
FIGURE 14.PHARMACEUTICAL GLYCERINE MARKET BY REGION,2020
FIGURE 15.U.S. PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 16.CANADA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 17.MEXICO PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 18.GERMANY PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 19.FRANCE PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 20.UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 21.ITALY PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 22.SPAIN PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 23.REST OF EUROPE PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 24.JAPAN PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 25.CHINA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 26.AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 27.INDIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 28.SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 29.REST OF ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 30.BRAZIL PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 31.SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 32.SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 33.REST OF LAMEA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)
FIGURE 34. TOP WINNING STRATEGIES, BY YEAR
FIGURE 35. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 36. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 37.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 38.COMPETITIVE DASHBOARD
FIGURE 39.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 40.DUPONT.: NET SALES ,($MILLION)
FIGURE 41.CARGILL.: NET SALES ,($MILLION)
FIGURE 42.UNIVERSAL PRESERV A CHEM INC..: NET SALES ,($MILLION)
FIGURE 43.TCC GLYCERIN.: NET SALES ,($MILLION)
FIGURE 44.PROCTER AND GAMBLE CO.: NET SALES ,($MILLION)
FIGURE 45.GODREJ GROUP.: NET SALES ,($MILLION)
FIGURE 46.EMERY OLEOCHEMICALS GROUP.: NET SALES ,($MILLION)
FIGURE 47.ARCHER DANIELS MIDLAND COMPANY.: NET SALES ,($MILLION)
FIGURE 48.RENEWABLE ENERGY GROUP, INC..: NET SALES ,($MILLION)
FIGURE 49.REAGENTS COMPANY.: NET SALES ,($MILLION)

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

Allied Market Research社のその他分野での最新刊レポート


よくあるご質問


Allied Market Research社はどのような調査会社ですか?


アライドマーケットリサーチ(Allied Market Research)は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る